SCHEMBL16022127

SCHEMBL16022127

CNCCC(=O)N1CC[C@H](Nc2ncc3nnn(-c4ccc(OC)cc4)c3n2)C1

nearest known ligand 0.62

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ MAPK6 Q16659 10/20 0.62
▸ GSK3A P49840 3/20 0.46
▸ GSK3B P49841 3/20 0.46
▸ EIF2AK4 Q9P2K8 1/20 0.44
▸ CCNA2 P20248 4/20 0.43
▸ CDK2 P24941 4/20 0.43
▸ CDK7 P50613 4/20 0.43
▸ CCNH P51946 4/20 0.43
▸ MNAT1 P51948 4/20 0.43
▸ CCNK O75909 3/20 0.43
▸ CDK12 Q9NYV4 3/20 0.43
▸ GFER P55789 1/20 0.42
▸ AURKA O14965 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16022035 1.00 MAPK6 (0.62) MAPK6GSK3AGSK3BEIF2AK4CCNA2
SCHEMBL16013085 0.90 MAPK6 (0.62) MAPK6GSK3AGSK3BEIF2AK4CCNA2
SCHEMBL16012829 0.90 MAPK6 (0.62) MAPK6GSK3AGSK3BEIF2AK4CCNA2
SCHEMBL16012828 0.90 MAPK6 (0.62) MAPK6GSK3AGSK3BEIF2AK4CCNA2
SCHEMBL16022126 0.89 MAPK6 (0.64) MAPK6GSK3AGSK3BEIF2AK4CCNA2
SCHEMBL18813107 0.89 MAPK6 (0.64) MAPK6GSK3AGSK3BEIF2AK4CCNA2
SCHEMBL16022088 0.89 MAPK6 (0.64) MAPK6GSK3AGSK3BEIF2AK4CCNA2
SCHEMBL16012197 0.88 MAPK6 (0.60) MAPK6GSK3AGSK3BEIF2AK4CCNA2
SCHEMBL16012196 0.88 MAPK6 (0.60) MAPK6GSK3AGSK3BEIF2AK4CCNA2
Formic Acid SCHEMBL16012727 0.88 MAPK6 (0.59) MAPK6GSK3AGSK3BEIF2AK4CCNA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014135244-A1 TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF DISEASES SUCH AS CANCER MERCK PATENT GMBH (DE) 2014-09-12 — — WO disclosed
Send feedback